Cargando…
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism
Mutations in the Myelin Protein Zero gene (MPZ), encoding P0, the major structural glycoprotein of peripheral nerve myelin, are the cause of Charcot–Marie-Tooth (CMT) type 1B neuropathy, and most P0 mutations appear to act through gain-of-function mechanisms. Here, we investigated how misglycosylati...
Autores principales: | Veneri, Francesca A, Prada, Valeria, Mastrangelo, Rosa, Ferri, Cinzia, Nobbio, Lucilla, Passalacqua, Mario, Milanesi, Maria, Bianchi, Francesca, Del Carro, Ubaldo, Vallat, Jean-Michel, Duong, Phu, Svaren, John, Schenone, Angelo, Grandis, Marina, D’Antonio, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759335/ https://www.ncbi.nlm.nih.gov/pubmed/35908287 http://dx.doi.org/10.1093/hmg/ddac170 |
Ejemplares similares
-
Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice
por: Bai, Yunhong, et al.
Publicado: (2022) -
Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT
por: Prada, Valeria, et al.
Publicado: (2021) -
Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice
por: Volpi, Vera G., et al.
Publicado: (2019) -
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A
por: Visigalli, Davide, et al.
Publicado: (2020) -
Transient hyperglycosylation of rhodopsin with galactose
por: Smith, Sylvia B., et al.
Publicado: (1991)